INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.

DBA: INSTITUTE FOR CLINICAL PHARMACODYNAMICS INC

SCHENECTADY, NEW YORK 123052504

Minority Owned
$1.68M
Total Contract Value
16 awards
First Award
Sep 21, 2022
Last Award
Aug 25, 2025
Business Size
small
CAGE Code
6Y2X5

Top Industries (NAICS)

NAICS CodeObligationsAwards
541714$803K9
541720$291K2

Contract Awards

4 awards found

75F40124C00080
Department of Health and Human Services
$249K
Aug 19, 2024

FDABAA-24-00123: DEVELOPMENT OF MODERNIZED SUSCEPTIBILITY GUIDANCE FOR NITROFURANTOIN DOSING USING A DYNAMIC URINARY TRACT IN VITRO INFECTION MODEL AND PHARMACOMETRIC APPROACHES - FY24C3BP4

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
75F40123C00140
Department of Health and Human Services
$263K
Sep 18, 2023

THIS IS A FIRM FIXED PRICE CONTRACT FOR DEVELOPMENT OF MODERNIZED SUSCEPTIBILITY GUIDANCE FOR AMPICILLIN AND VANCOMYCIN FOR ENTEROCOCCUS SPECIES USING PHARMACOMETRIC APPROACHES

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
75F40122C00174
Department of Health and Human Services
$291K
Sep 22, 2022

A STUDY IN THE "DEVELOPMENT OF MODERNIZED SUSCEPTIBILITY GUIDANCE FOR ORAL SULFAMETHOXAZOLE-TRIMETHOPRIM USING PHARMACOMETRICS APPROACHES" BAA PMWP #195

NAICS: 541720 - RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIESFY2022
75F40122C00180
Department of Health and Human Services
$292K
Sep 21, 2022

COMBATTING ANTIBIOTIC RESISTANT BACTERIA (CARB) PROGRAM

NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2022

Business Details

UEI
Z82HHPY83MC7
CAGE Code
6Y2X5
Address
242 BROADWAY STE 101
STE 101
SCHENECTADY, NY 123052504
Congressional District
NY-20

Parent Company

INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov